Type 2 diabetes monitoring and control in migrants and non-migrants: A population-based cohort study in primary care in the Netherlands

IF 2.3 4区医学 Q3 ENDOCRINOLOGY & METABOLISM

Primary Care Diabetes Pub Date : 2026-02-01 Epub Date: 2025-10-15 DOI:10.1016/j.pcd.2025.10.003

B.T. Strooij , S. Remmelzwaal , M. Muilwijk , J.A. Overbeek , R.M.C. Herings , P.J.M. Elders , H.P.J. van Hout , O.R. Maarsingh , I.G.M. van Valkengoed , M.T. Blom

{"title":"Type 2 diabetes monitoring and control in migrants and non-migrants: A population-based cohort study in primary care in the Netherlands","authors":"B.T. Strooij , S. Remmelzwaal , M. Muilwijk , J.A. Overbeek , R.M.C. Herings , P.J.M. Elders , H.P.J. van Hout , O.R. Maarsingh , I.G.M. van Valkengoed , M.T. Blom","doi":"10.1016/j.pcd.2025.10.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Type 2 diabetes (T2D) disproportionally affects migrants. We compared T2D-care in primary care between migrants and non-migrants in the Netherlands.</div></div><div><h3>Methods</h3><div>We performed a dynamic cohort study based on routine care data (2015–2019) from the DIAbetes MANagement and Treatment (DIAMANT) cohort linked to databases of Statistics Netherlands. Persons aged ≥ 35years with T2D treated in primary care were included. Outcomes included annual monitoring of HbA1c, systolic blood pressure and LDL; meeting of treatment targets; and medication prescription. Generalized estimating equations logistic regression models estimated the associations between having a migration background and outcomes.</div></div><div><h3>Results</h3><div>We included 165,670 persons: 83.7 % non-migrants, 2.1 % Turkish, 3.0 % Moroccan, 2.1 % Surinamese, 3.3 % European, and 5.7 % other non-European migrants. Most migrant groups had similar or higher odds of having annual monitoring compared to non-migrants, but lower odds of meeting the HbA1c and LDL treatment targets, with the lowest odds for Turkish migrants (OR 0.61, 95 %-CI 0.57–0.64; OR 0.86, 95 %-CI 0.81–0.91). Exploratory analyses demonstrated insulins to be less often prescribed to migrants.</div></div><div><h3>Conclusions</h3><div>Most migrant groups were equally or better monitored for T2D-parameters compared to non-migrants, but were less likely to meet HbA1c targets. This might partly reflect the less frequent insulin prescriptions to migrants. Further research is needed on underlying mechanisms and the specific needs of migrant groups to optimize T2D-care for all.</div></div>","PeriodicalId":48997,"journal":{"name":"Primary Care Diabetes","volume":"20 1","pages":"Pages 53-60"},"PeriodicalIF":2.3000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Diabetes","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1751991825001962","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

Type 2 diabetes (T2D) disproportionally affects migrants. We compared T2D-care in primary care between migrants and non-migrants in the Netherlands.

Methods

We performed a dynamic cohort study based on routine care data (2015–2019) from the DIAbetes MANagement and Treatment (DIAMANT) cohort linked to databases of Statistics Netherlands. Persons aged ≥ 35years with T2D treated in primary care were included. Outcomes included annual monitoring of HbA1c, systolic blood pressure and LDL; meeting of treatment targets; and medication prescription. Generalized estimating equations logistic regression models estimated the associations between having a migration background and outcomes.

Results

We included 165,670 persons: 83.7 % non-migrants, 2.1 % Turkish, 3.0 % Moroccan, 2.1 % Surinamese, 3.3 % European, and 5.7 % other non-European migrants. Most migrant groups had similar or higher odds of having annual monitoring compared to non-migrants, but lower odds of meeting the HbA1c and LDL treatment targets, with the lowest odds for Turkish migrants (OR 0.61, 95 %-CI 0.57–0.64; OR 0.86, 95 %-CI 0.81–0.91). Exploratory analyses demonstrated insulins to be less often prescribed to migrants.

Conclusions

Most migrant groups were equally or better monitored for T2D-parameters compared to non-migrants, but were less likely to meet HbA1c targets. This might partly reflect the less frequent insulin prescriptions to migrants. Further research is needed on underlying mechanisms and the specific needs of migrant groups to optimize T2D-care for all.

查看原文本刊更多论文

移民和非移民的2型糖尿病监测和控制：荷兰一项基于人群的初级保健队列研究

目的：2型糖尿病（T2D）对移民的影响不成比例。我们比较了荷兰移民和非移民在初级保健中的t2d护理。方法：我们基于与荷兰统计局数据库相关联的糖尿病管理和治疗（DIAMANT）队列的常规护理数据（2015-2019）进行了一项动态队列研究。年龄≥ ，35岁，接受初级保健治疗的T2D患者。结果包括每年监测HbA1c、收缩压和LDL；达到治疗目标；还有药物处方。广义估计方程逻辑回归模型估计具有迁移背景和结果之间的关联。结果：我们纳入了165,670人：83.7 %非移民，2.1 %土耳其人，3.0 %摩洛哥人，2.1 %苏里南人，3.3 %欧洲人和5.7 %其他非欧洲移民。与非移民相比，大多数移民群体每年进行监测的几率相似或更高，但达到HbA1c和LDL治疗目标的几率较低，土耳其移民的几率最低（or 0.61, 95 %-CI 0.57-0.64; or 0.86, 95 %-CI 0.81-0.91）。探索性分析表明，移民较少使用胰岛素。结论：与非移民相比，大多数移民群体的t2d参数监测相同或更好，但达到HbA1c目标的可能性较小。这可能在一定程度上反映了给移民开胰岛素的频率较低。需要进一步研究移民群体的潜在机制和具体需求，以优化所有人的t2d护理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Primary Care Diabetes ENDOCRINOLOGY & METABOLISM-PRIMARY HEALTH CARE

CiteScore

5.00

自引率

3.40%

发文量

134

审稿时长

47 days

期刊介绍： The journal publishes original research articles and high quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology and other areas as far as is relevant for diabetology in a primary-care setting. The purpose of the journal is to encourage interdisciplinary research and discussion between all those who are involved in primary diabetes care on an international level. The Journal also publishes news and articles concerning the policies and activities of Primary Care Diabetes Europe and reflects the society''s aim of improving the care for people with diabetes mellitus within the primary-care setting.